170 related articles for article (PubMed ID: 31010144)
1. A Water-Soluble Microencapsulated Milk Thistle Extract as Active Ingredient for Dermal Formulations.
Esposito T; Sansone F; Russo P; Picerno P; Aquino RP; Gasparri F; Mencherini T
Molecules; 2019 Apr; 24(8):. PubMed ID: 31010144
[TBL] [Abstract][Full Text] [Related]
2. Application of Spray Drying Particle Engineering to a High-Functionality/Low-Solubility Milk Thistle Extract: Powders Production and Characterization.
Sansone F; Esposito T; Lauro MR; Picerno P; Mencherini T; Gasparri F; De Santis S; Chieppa M; Cirillo C; Aquino RP
Molecules; 2018 Jul; 23(7):. PubMed ID: 30011893
[TBL] [Abstract][Full Text] [Related]
3. A new approach to enhance oral bioavailability of Silybum Marianum dry extract: association of mechanochemical activation and spray congealing.
Passerini N; Perissutti B; Albertini B; Franceschinis E; Lenaz D; Hasa D; Locatelli I; Voinovich D
Phytomedicine; 2012 Jan; 19(2):160-8. PubMed ID: 21802925
[TBL] [Abstract][Full Text] [Related]
4. Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.
Cufí S; Bonavia R; Vazquez-Martin A; Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Martin-Castillo B; Barrajón-Catalán E; Visa J; Segura-Carretero A; Bosch-Barrera J; Joven J; Micol V; Menendez JA
Food Chem Toxicol; 2013 Oct; 60():360-8. PubMed ID: 23916468
[TBL] [Abstract][Full Text] [Related]
5. Antiosteoclastic activity of milk thistle extract after ovariectomy to suppress estrogen deficiency-induced osteoporosis.
Kim JL; Kim YH; Kang MK; Gong JH; Han SJ; Kang YH
Biomed Res Int; 2013; 2013():919374. PubMed ID: 23781510
[TBL] [Abstract][Full Text] [Related]
6. Combinations of grape seed procyanidin extract and milk thistle silymarin extract against lung cancer - The role of MiR-663a and FHIT.
Mao JT; Xue B; Lu QY; Lundmark L; Burns W; Yang J; Lee RP; Glass J; Qualls C; Massie L
Life Sci; 2023 Apr; 318():121492. PubMed ID: 36775115
[TBL] [Abstract][Full Text] [Related]
7. Improving the water solubility and antimicrobial activity of silymarin by nanoencapsulation.
Lee JS; Hong DY; Kim ES; Lee HG
Colloids Surf B Biointerfaces; 2017 Jun; 154():171-177. PubMed ID: 28340483
[TBL] [Abstract][Full Text] [Related]
8. Oral bioavailability of silymarin phytocomplex formulated as self-emulsifying pellets.
Iosio T; Voinovich D; Perissutti B; Serdoz F; Hasa D; Grabnar I; Acqua SD; Zara GP; Muntoni E; Pinto JF
Phytomedicine; 2011 Apr; 18(6):505-12. PubMed ID: 21111585
[TBL] [Abstract][Full Text] [Related]
9. Formulation of microemulsion systems for dermal delivery of silymarin.
Panapisal V; Charoensri S; Tantituvanont A
AAPS PharmSciTech; 2012 Jun; 13(2):389-99. PubMed ID: 22350738
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract.
Wen Z; Dumas TE; Schrieber SJ; Hawke RL; Fried MW; Smith PC
Drug Metab Dispos; 2008 Jan; 36(1):65-72. PubMed ID: 17913795
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effect of hydroxypropyl-β-cyclodextrin on topical administration of milk thistle extract.
Spada G; Gavini E; Cossu M; Rassu G; Carta A; Giunchedi P
Carbohydr Polym; 2013 Jan; 92(1):40-7. PubMed ID: 23218263
[TBL] [Abstract][Full Text] [Related]
12. Hydrogel-thickened nanoemulsions based on essential oils for topical delivery of psoralen: Permeation and stability studies.
Barradas TN; Senna JP; Cardoso SA; Nicoli S; Padula C; Santi P; Rossi F; de Holanda E Silva KG; Mansur CRE
Eur J Pharm Biopharm; 2017 Jul; 116():38-50. PubMed ID: 27867112
[TBL] [Abstract][Full Text] [Related]
13. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.
Bijak M
Molecules; 2017 Nov; 22(11):. PubMed ID: 29125572
[TBL] [Abstract][Full Text] [Related]
14. Poor chemical and microbiological quality of the commercial milk thistle-based dietary supplements may account for their reported unsatisfactory and non-reproducible clinical outcomes.
Fenclova M; Novakova A; Viktorova J; Jonatova P; Dzuman Z; Ruml T; Kren V; Hajslova J; Vitek L; Stranska-Zachariasova M
Sci Rep; 2019 Jul; 9(1):11118. PubMed ID: 31366891
[TBL] [Abstract][Full Text] [Related]
15. Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis.
Mady FM; Essa H; El-Ammawi T; Abdelkader H; Hussein AK
Drug Des Devel Ther; 2016; 10():1101-10. PubMed ID: 27022248
[TBL] [Abstract][Full Text] [Related]
16. Neural Network-based Optimization of
Hanafi A; Safa KD; Rezazadeh S
Curr Comput Aided Drug Des; 2023; 19(1):2-12. PubMed ID: 36221887
[TBL] [Abstract][Full Text] [Related]
17. Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation.
Yang KY; Hwang du H; Yousaf AM; Kim DW; Shin YJ; Bae ON; Kim YI; Kim JO; Yong CS; Choi HG
Int J Nanomedicine; 2013; 8():3333-43. PubMed ID: 24039417
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the analysis of flavonolignans of Silybum marianum.
Csupor D; Csorba A; Hohmann J
J Pharm Biomed Anal; 2016 Oct; 130():301-317. PubMed ID: 27321822
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant and hepatoprotective effects of silymarin phytosomes compared to milk thistle extract in CCl4 induced hepatotoxicity in rats.
El-Gazayerly ON; Makhlouf AI; Soelm AM; Mohmoud MA
J Microencapsul; 2014; 31(1):23-30. PubMed ID: 23808477
[TBL] [Abstract][Full Text] [Related]
20. Milk thistle (Silybum marianum (L.)Gaertn.): An overview about its pharmacology and medicinal uses with an emphasis on oral diseases.
Eita AAB
J Oral Biosci; 2022 Mar; 64(1):71-76. PubMed ID: 34968721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
